Biofarm Bucure (BIO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.054x

Based on the latest financial reports, Biofarm Bucure (BIO) has a cash flow conversion efficiency ratio of 0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RON28.64 Million ≈ $6.58 Million USD) by net assets (RON534.78 Million ≈ $122.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Biofarm Bucure - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Biofarm Bucure's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Biofarm Bucure debt and liabilities for a breakdown of total debt and financial obligations.

Biofarm Bucure Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biofarm Bucure ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Can2 Termik AS
IS:CANTE
0.020x
Hung Ching Development & Construction Co Ltd
TW:2527
-0.026x
Lanzhou Huanghe Enterprise Co Ltd
SHE:000929
-0.145x
Jindal Worldwide Limited
NSE:JINDWORLD
0.105x
Sappe Public Company Limited
BK:SAPPE
0.070x
Planigrupo LATAM S.A.B. de C.V
MX:PLANI
0.043x
Roman DBDR Acquisition Corp. II Unit
NASDAQ:DRDBU
-0.001x
Adel Kalemcilik Ticaret ve Sanayi AS
IS:ADEL
-0.453x

Annual Cash Flow Conversion Efficiency for Biofarm Bucure (2019–2024)

The table below shows the annual cash flow conversion efficiency of Biofarm Bucure from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Biofarm Bucure market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-09-30 RON478.26 Million
≈ $109.82 Million
RON57.59 Million
≈ $13.22 Million
0.120x -34.47%
2023-09-30 RON434.41 Million
≈ $99.75 Million
RON79.83 Million
≈ $18.33 Million
0.184x +140.68%
2022-09-30 RON380.06 Million
≈ $87.27 Million
RON29.02 Million
≈ $6.66 Million
0.076x -63.27%
2021-09-30 RON332.79 Million
≈ $76.41 Million
RON69.18 Million
≈ $15.89 Million
0.208x +53.41%
2020-09-30 RON291.55 Million
≈ $66.94 Million
RON39.51 Million
≈ $9.07 Million
0.136x -52.22%
2019-09-30 RON257.23 Million
≈ $59.06 Million
RON72.96 Million
≈ $16.75 Million
0.284x --

About Biofarm Bucure

RO:BIO Romania Drug Manufacturers - Specialty & Generic
Market Cap
$280.56 Million
RON1.22 Billion RON
Market Cap Rank
#15233 Global
#22 in Romania
Share Price
RON1.24
Change (1 day)
-0.80%
52-Week Range
RON0.65 - RON1.34
All Time High
RON1.34
About

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescr… Read more